AG
SURF

Advisor Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Advisor Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-700
Closed -$2K – 5480
2019
Q2 		$2K Hold
700
– – ﹤0.01% 5026
2019
Q1 		$3K Buy
700
+400
+133% +$1.97K ﹤0.01% 4886
2018
Q4 		$1K Hold
300
– – ﹤0.01% 5029
2018
Q3 		$3K Buy
+300
New +$3.52K ﹤0.01% 4779

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisor Group's SURF Position: Q3 2019 in Review

Advisor Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2019, closing a stake of 700 shares — an estimated $2K sold.

Advisor Group first reported a position in SURF in Q3 2018 and held it in 4 quarters. The position peaked at $3K in Q1 2019. 35 funds tracked by Wall St. Rank hold SURF as of Q3 2019.

  • Advisor Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Advisor Group sold 700 Surface Oncology, Inc. Common Stock shares in Q3 2019, an estimated $2K.
  • Advisor Group first reported a position in Surface Oncology, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Advisor Group's Surface Oncology, Inc. Common Stock position peaked at $3K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.